1. Home
  2. Bills
  3. H.R. 1503

H.R. 1503 · 116th Congress · 2019–2020

Orange Book Transparency Act of 2020

H.R. 1503 in the 116th Congress (2019–2020) became law — introduced on Mar 5, 2019, sponsored by Robin L. Kelly with 13 co-sponsors. Congress held 1 roll call vote on it.

During the 116th Congress (2019–2020), Donald Trump was president, and Democrats held the House majority and Republicans the Senate majority.

Status
Became law
Introduced
Mar 5, 2019
Co-sponsors
13
Policy area
Health
Public law
Public Law 116-290

What it does

Orange Book Transparency Act of 2020 This bill modifies requirements for the Food and Drug Administration (FDA)to list and publish drug patent and exclusivity information. Specifically, the FDA must include on its list certain patent information and must specify each drug exclusivity period that has not concluded.

Summary by the nonpartisan Congressional Research Service.

Sponsor

Robin L. Kelly (D-IL). Co-sponsors: 12 Democrats, 1 Republican.

Where it stands

  • IntroducedMar 5, 2019
  • Passed the HouseMay 8, 2019
  • Passed the SenateDec 7, 2020
  • Sent to the PresidentDec 24, 2020
  • Became lawJan 5, 2021

Latest action: Became Public Law No: 116-290. (Jan 5, 2021)

How Congress voted

  • On Motion to Suspend the Rules and Pass, as Amended
    House · May 8, 2019 · Passed
    422–0

Every roll call vote on this bill

More bills from Robin L. Kelly in the 116th Congress

Other Health bills in the 116th Congress

Committees

More

From GovInfo bill records, Congressional Research Service summaries, Voteview roll calls and lobbying reports.

Cite or embed this page

Capitol Receipts, “H.R. 1503 (116th Congress): Orange Book Transparency Act of 2020,” https://www.capitolreceipts.com/bill/116-hr-1503/orange-book-transparency-act-of-2020 (accessed 2026-10-17).